MedTech Forum 2025

๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—™๐—ฒ๐—ฎ๐˜€๐—ถ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฆ๐˜๐˜‚๐—ฑ๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ

The #MTF2025 event in Lisbon, Portugal was a significant milestone for the project, which aims to revolutionize Early Feasibility Studies (EFS) for medical devices in Europe.

๐—ž๐—ฒ๐˜† ๐—ง๐—ฎ๐—ธ๐—ฒ๐—ฎ๐˜„๐—ฎ๐˜†๐˜€

  1. ๐—–๐—ผ๐—น๐—น๐—ฎ๐—ฏ๐—ผ๐—ฟ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—˜๐—ณ๐—ณ๐—ผ๐—ฟ๐˜๐˜€: The session highlighted the power of collaboration among industry, academia, healthcare, and patient associations. This cross-sectoral partnership is crucial for developing a harmonized EFS methodology.
  2. ๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜-๐—–๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ ๐—”๐—ฝ๐—ฝ๐—ฟ๐—ผ๐—ฎ๐—ฐ๐—ต: Integrating patient input ensures that medical devices are tailored to patient needs, enhancing their effectiveness and acceptance.
  3. ๐—–๐—น๐—ฒ๐—ฎ๐—ฟ ๐—š๐˜‚๐—ถ๐—ฑ๐—ฎ๐—ป๐—ฐ๐—ฒ: Providing a roadmap for EFS will streamline processes for innovative companies, hospitals, and competent HTA authorities, making Europe a more attractive location for medical device innovation.

๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—œ๐—บ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€

  1. ๐—•๐—ผ๐—ผ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ๐—ป๐—ฒ๐˜€๐˜€: A harmonized EFS methodology will enhance Europeโ€™s competitiveness in the global medical device market.
  2. ๐—”๐—ฐ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: Well-run EFS will speed up the development and patient access to innovative devices, ultimately improving healthcare outcomes.
  3. ๐—ฅ๐—ฒ๐—ฎ๐—น-๐—ช๐—ผ๐—ฟ๐—น๐—ฑ ๐—œ๐—บ๐—ฝ๐—น๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป: The involvement of all stakeholders, driven by a common objective, increases the likelihood of successful implementation in the real world.

Next Steps

  1. ๐—–๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ๐—ฑ ๐—–๐—ผ๐—น๐—น๐—ฎ๐—ฏ๐—ผ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: We will continue to work closely with our partners to refine and implement the EFS methodology.
  2. ๐—˜๐—ป๐—ด๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ฎ๐—ป๐—ฑ ๐—™๐—ฒ๐—ฒ๐—ฑ๐—ฏ๐—ฎ๐—ฐ๐—ธ: Ongoing engagement with stakeholders will be essential to ensure the methodology meets the needs of all parties involved.

Thank you to the moderator and excellent speakers at #MTF2025 for their insightful contributions and for making complex issues accessible and engaging to a wider audience.

Moderator

Niklas Blomberg, Innovative Health Initiative (IHI)

Speakers

Innovative Health Initiative (IHI) MedTech Europe EFPIA – European Federation of Pharmaceutical Industries and Associations COCIR EuropaBio – the European Association for Bioindustries Vaccines Europe

#IHITransformingHealth #PatientCare #EvidenceGeneration

Followย us on LinkedIn and X to stay updated with the HEU-EFSโ€™ progress and outcomes.
Subscribe to our newsletter for the latest news delivered straight to your inbox.